Hemoglobinopathy Treatments
Find Hemoglobinopathy Treatments
Brand Name
Ferriprox
Generic Name
Deferiprone
View Brand Information FDA approval date: September 09, 2015
Classification: Iron Chelator
Form: Tablet, Solution
What is Ferriprox (Deferiprone)?
FERRIPROX Tablets are an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes.
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Summary: The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.
Early Detection and Management of Cardiac Iron Overload in Sickle Cell Disease Using Multimodal Imaging for Improved Clinical Outcomes
Summary: This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.